Standard BioTools Net Cash Flow 2010-2025 | LAB

Standard BioTools net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

Standard BioTools Net Cash Flow 2010-2025 | LAB

Standard BioTools net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.6B
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.4B
Hims & Hers Health (HIMS)$9.7B
IRhythm Technologies (IRTC)$5.3B
Hinge Health (HNGE)$4.3B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.6B
Heartflow (HTFL)$2.4B
Phreesia (PHR)$1.8B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$659M
Zepp Health (ZEPP)$570M
Veradigm (MDRX)$525M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$390M
Carlsmed (CARL)$380M
TruBridge (TBRG)$298M
Outset Medical (OM)$244M
Health Catalyst (HCAT)$235M
SOPHiA GENETICS SA (SOPH)$233M
Nyxoah SA (NYXH)$220M
KORU Medical Systems (KRMD)$194M